Recursion Pharmaceuticals
Combines automation and machine learning to industrialize drug discovery and development.
What they do
Recursion Pharmaceuticals uses automated biology, high throughput imaging, and machine learning to decode human cellular biology. The company licenses their discovery platform and drug pipeline to global biopharma companies looking to accelerate therapeutic breakthroughs.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- AI drug discovery
- Product type
- Platform software
- Stage
- Public
- Headquarters
- Salt Lake City, United States
- Region
- North America
- Founded
- 2013
- Total funding
- $665M raised
Notable investors: Mubadala Investment Company, Baillie Gifford, Lux Capital, Two Sigma Ventures.